Skip to main content

Table 2 The immunomodulatory treatments the analyzed patients underwent after blood sampling.

From: Prediction of acute multiple sclerosis relapses by transcription levels of peripheral blood cells

  CIS Definite MS Non treated patients Interferon β-1a Avonex Interferon β-1b Betaferon Interferon β-1a Rebif Glatiramer acetate Copaxone Intravenous Immunoglobulins Iv-Ig
No of Patients 32 62 61 5 2 10 10 6